Cargando…
Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London
BACKGROUND: Excess prescription and use of short-acting beta-agonist (SABA) inhalers is associated with poor asthma control and increased risk of hospital admission. AIM: To quantify the prevalence and identify the predictors of SABA overprescribing. DESIGN AND SETTING: A cross-sectional study using...
Autores principales: | De Simoni, Anna, Hajmohammadi, Hajar, Pfeffer, Paul, Cole, Jim, Griffiths, Chris, Hull, Sally A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423045/ https://www.ncbi.nlm.nih.gov/pubmed/35995577 http://dx.doi.org/10.3399/BJGP.2021.0725 |
Ejemplares similares
-
Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study
por: Pfeffer, Paul, et al.
Publicado: (2023) -
Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London
por: Hull, Sally A, et al.
Publicado: (2016) -
Reducing Opioid Overprescribing through Procedure-specific Prescribing Guidelines
por: Zhang, Kevin K., et al.
Publicado: (2023) -
Missing PPI prescriptions while overprescribing?
por: Schubert, Ingrid, et al.
Publicado: (2023) -
Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London
por: Cole, James N., et al.
Publicado: (2020)